iStock-1175599815.jpg

A Revolution Towards A Cure

We combine precision stem cell engineering, highly-scalable cell manufacturing,

and NK-activating antibodies to unlock the full potential of Natural Killer Cells as the safest, most effective, most broadly-available first line of defense against cancer.

 
Screen_20Shot_202020-07-05_20at_2010_edi

Precision NK therapies have the potential to revolutionize cancer treatment with unsurpassed safety and efficacy. We are excited to bring NK Cell Engager antibodies and CAR-NK cell therapies to initial clinical trials starting in 2021, moving towards broad patient access to cancer-defeating cures."

Dr. Daniel Teper,

Cytovia Therapeutics CEO